Related Experiment Video
Updated: May 9, 2026
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Metasignatures identify two major subtypes of breast cancer
1Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
CPT: Pharmacometrics & Systems Pharmacology
|July 10, 2013
Summary
This study integrates breast cancer cell line data with tumor expression and drug responses to identify patient clusters. Findings reveal distinct patient groups based on epigenetic marks, guiding personalized drug therapies for better outcomes.
Area of Science:
- Genomics
- Systems Biology
- Pharmacology
Background:
- Breast cancer personalized therapy requires integrating diverse molecular and drug response data.
- Existing methods for linking cell line expression to tumor subtypes have limitations.
Purpose of the Study:
- To develop integrative analyses for personalized breast cancer therapy.
- To identify novel patient clusters and dysregulated pathways using gene expression and drug response data.
- To recommend individualized drug treatments for specific patient subsets.
Main Methods:
- Generated tripartite networks connecting patients, cell lines, and drugs.
- Applied standard biomarker gene set methods and novel metasignature approaches.
- Utilized transcription factor and histone modification data for patient clustering.
Main Results:
- Identified two major patient clusters based on active and repressive histone marks.
- Found that tumors enriched for active histone marks correlate with poor prognosis.
- Discovered dysregulated pathways and potential drug targets within patient subsets.
Conclusions:
- The study proposes a new patient clustering strategy for breast cancer.
- Integrative network analysis can reveal insights into tumor biology and drug sensitivity.
- Results support the individualized use of drugs for treating specific breast cancer patient groups.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...